The effect of high doses of 25-hydroxycholecalciferol on plasma calcium concentration was studied in rats receiving a low-calcium normal vitamin D diet. In bilaterally nephrectomized animals, as in sham-operated controls, 62.5 nmol of 25-hyroxycholecalciferol did not produce a rise of plasma calcium concentration. In contrast, the administration of 125 or 625 nmol, doses 1,000-5,000 times the minimal active dose in D-deficient rats, was followed in both groups of animals by a significant increase of plasma calcium concentration. Removal of either parathyroids alone or parathyroid and thyroid glands did not suppress this effect. These data suggest that when large doses are used in vivo, the renal conversion of 25-hydroxycholecalciferol to more polar metabolites is not an obligatory step for its calcium-mobilizing action. The present study does not elucidate, however, the exact mechanism(s) of this effect.
Henriette Pavlovitch, Michele Garabedian, Sonia Balsan
Title and authors | Publication | Year |
---|---|---|
Place de la vitamine D native en dialyse
P Delanaye, A Bouquegneau, JM Krzesinski, É Cavalier, G Jean, P Urena-Torres, JC Souberbielle |
Néphrologie & Thérapeutique | 2015 |
Vitamin D: Deficiency, Sufficiency and Toxicity
F Alshahrani, N Aljohani |
Nutrients | 2013 |
Vitamin D Metabolites; Protective versus Toxic Properties: Molecular and Cellular Perspectives
MS Ahmed, A Shoker |
2010 | |
Vitamin D
A Portale, Β Halloran, E Lonergan, R Morris |
Vitamin D | 1988 |
Vitamin d toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis
MS Schwartzman, WA Franck |
The American Journal of Medicine | 1987 |
The relationship of adequate and excessive intake of vitamin D to health and disease
RP Holmes, FA Kummerow |
Journal of the American College of Nutrition | 1983 |
Suppressive effects of 24,25-dihydroxycholecalciferol on bone resorption induced by acute bilateral nephrectomy in rats
JH Pavlovitch, G Cournot-Witmer, A Bourdeau, S Balsan, JA Fischer, G Heynen |
Journal of Clinical Investigation | 1981 |
Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes
RM Shepard, HF Deluca |
Archives of Biochemistry and Biophysics | 1980 |
Verhandlungen der Deutschen Gesellschaft für innere Medizin
B Schlegel |
1980 | |
Einflu� der Vitamin-D3-Therapie auf die renale Osteodystrophie im Kindesalter
M Bulla, , G Delling, H Hofmann, G Offermann |
Klinische Wochenschrift | 1980 |
The Vitamin D System in the Regulation of Calcium and Phosphorus Metabolism
HF DeLuca |
Nutrition Reviews | 1979 |
Recent advances in our understanding of the vitamin D endocrine system
HF Deluca |
Journal of Steroid Biochemistry | 1979 |
7 Hormonal aspects of vitamin D metabolism and its clinical implications
LV Avioli |
Clinics in Endocrinology and Metabolism | 1979 |
Hormonal Steroids
W Nowaczynski, P Landais, T Murakami, M Nowaczynski, D Mavoungou, B Vitullo |
Hormonal Steroids | 1979 |
Synthesis and biological activity of 24-hydroxy-25-fluorovitamin D3. A highly potent mediator of calcium metabolism
JL Napoli, WS Mellon, MA Fivizzani, HK Schnoes, HF DeLuca |
The Journal of biological chemistry | 1979 |
Effects of phenobarbital and diphenylhydantoin on acute vitamin D3 toxicity in the rat
M Gascon-Barré, MG Côté |
Toxicology and Applied Pharmacology | 1978 |
17alpha;-Hydroxy-25-fluorovitamin D 3 : a potent analog of 1α,25-dihydroxyvitamin D 3
JL Napoli, MA Fivizzani, HK Schnoes, HF DeLuca |
Biochemistry | 1978 |
Phosphate Control and 25-Hydroxycholecalciferol Administration in Preventing Experimental Renal Osteodystrophy in the Dog
WE Rutherford, P Bordier, P Marie, K Hruska, H Harter, A Greenwalt, J Blondin, J Haddad, N Bricker, E Slatopolsky |
Journal of Clinical Investigation | 1977 |
Vitamin D: Biochemistry and clinical applications
MJ Pitt, MR Haussler |
Skeletal Radiology | 1977 |
Serum 25-hydroxyvitamin D in patients with chronic renal disease
J Pietrek, F Kokot |
European Journal of Clinical Investigation | 1977 |
Metabolic Bone Disease
OL Bijvoet |
Metabolic Bone Disease | 1977 |
Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure
G Witmer, A Margolis, O Fontaine, J Fritsch, G Lenoir, M Broyer, S Balsan |
Kidney International | 1976 |
Recent advances in calcium metabolism
AW Root, HE Harrison |
The Journal of Pediatrics | 1976 |
Metabolism of Vitamin D
D Atkins, TJ Martin |
Annals of Clinical Biochemistry | 1976 |
25-Hydroxyvitamin D 3 : Autoradiographic Evidence of Sites of Action in Epiphyseal Cartilage and Bone
FH Wezeman |
Science | 1976 |
Metabolism and biologica
MF Holick, LA Baxter, PK Schraufrogel, TE Tavela, HF DeLuca |
The Journal of biological chemistry | 1976 |
Experimental renal osteodystrophy. The response to 25-hydroxycholecalciferol and dicholomethylene diphosphate therapy
JE Russell, JD Termine, LV Avioli |
Journal of Clinical Investigation | 1975 |
Effect of 25-hydroxycholecalciferol on calcium absorption in chronic renal disease
WE Rutherford, J Blondin, K Hruska, R Kopelman, S Klahr, E Slatopolsky |
Kidney International | 1975 |
Bone resorbing activities of 24-hydroxy stereoisomers of 24-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3
PH Stern, HF DeLuca, N Ikekawa |
Biochemical and Biophysical Research Communications | 1975 |
Calcium Metabolism, Bone and Metabolic Bone Diseases
F Kuhlencordt, HP Kruse |
1975 | |
Ultrastructural evaluation of the effects of vitamin D and uremia on bone in the rat
SE Weisbrode, CC Capen, LA Nagode |
The American Journal of Pathology | 1974 |
Metabolism of 25-hydroxyvitamin D3 in anephric rats: a new active metabolite
M Garabedian, H Pavlovitch, C Fellot, S Balsan |
Proceedings of the National Academy of Sciences | 1974 |
The therapeutic approach to hypoparathyroidism
LV Avioli |
The American Journal of Medicine | 1974 |